Improvement of impaired renal function in heart transplant recipients treated with mycophenolate mofetil and low-dose cyclosporine

Transplantation

Volumn 69, Issue 8, 2000, Pages 1586-1590

  Aleksic, Ivan ^a   Baryalei, Mersa ^a   Busch, Thomas ^a   Pieske, Burkert ^a   Schorn, Bernd ^a   Strauch, Justus ^a   Sîrbu, Horia ^a   Dalichau, Harald ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY; URIC ACID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; GRAFT VERSUS HOST REACTION; HEART DILATATION; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

EID: 0034720036     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004270-00012     Document Type: Article

References (16)

1. The Registry of the International Society for Heart and Lung Transplantation: Fifteenth Official Report - 1998
2. Nature and extent of glomerular injury induced by cyclosporine in heart transplant recipients
3. Cyclosporine-associated end-stage nephropathy after cardiac transplantation
4. The long-term course of cyclosporine associated chronic nephropathy
5. Cyclosporine nephrotoxicity in cardiac allograft patients: A seven-year follow-up
6. Renal transplant function after ten years of cyclosporine
7. Mycophenolate mofetil in renal transplant recipients with cyclosporine-associated nephrotoxicity
8. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression
9. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients
10. A working formulation for standardization of the nomenclature in the diagnosis of heart and lung rejection: Heart rejection study group
11. Post-transplant conversion from cyclosporin to azathioprine: Effect on cardiovascular risk profile
12. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation
13. Mycophenolate mofetil in renal allograft recipients
14. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
15. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation
16. A novel approach to the treatment of chronic allograft nephropathy